Cargando…

Development of a highly specific serodiagnostic ELISA for West Nile virus infection using subviral particles

West Nile virus (WNV), a member of the Japanese encephalitis virus (JEV) serocomplex group, causes lethal encephalitis in humans and horses. Because serodiagnosis of WNV and JEV is hampered by cross-reactivity, the development of a simple, secure, and WNV-specific serodiagnostic system is required....

Descripción completa

Detalles Bibliográficos
Autores principales: Maezono, Keisuke, Kobayashi, Shintaro, Tabata, Koshiro, Yoshii, Kentaro, Kariwa, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080695/
https://www.ncbi.nlm.nih.gov/pubmed/33911132
http://dx.doi.org/10.1038/s41598-021-88777-5
_version_ 1783685488857579520
author Maezono, Keisuke
Kobayashi, Shintaro
Tabata, Koshiro
Yoshii, Kentaro
Kariwa, Hiroaki
author_facet Maezono, Keisuke
Kobayashi, Shintaro
Tabata, Koshiro
Yoshii, Kentaro
Kariwa, Hiroaki
author_sort Maezono, Keisuke
collection PubMed
description West Nile virus (WNV), a member of the Japanese encephalitis virus (JEV) serocomplex group, causes lethal encephalitis in humans and horses. Because serodiagnosis of WNV and JEV is hampered by cross-reactivity, the development of a simple, secure, and WNV-specific serodiagnostic system is required. The coexpression of prM protein and E protein leads to the secretion of subviral particles (SPs). Deletion of the C-terminal region of E protein is reported to affect the production of SPs by some flaviviruses. However, the influence of such a deletion on the properties and antigenicity of WNV E protein is unclear. We analyzed the properties of full-length E protein and E proteins lacking the C-terminal region as novel serodiagnostics for WNV infection. Deletion of the C-terminal region of E protein suppressed the formation of SPs but did not affect the production of E protein. The sensitivity of an enzyme-linked immunosorbent assay (ELISA) using the full-length E protein was higher than that using the truncated E proteins. Furthermore, in the ELISA using full-length E protein, there was little cross-reactivity with anti-JEV antibodies, and the sensitivity was similar to that of the neutralization test.
format Online
Article
Text
id pubmed-8080695
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-80806952021-04-30 Development of a highly specific serodiagnostic ELISA for West Nile virus infection using subviral particles Maezono, Keisuke Kobayashi, Shintaro Tabata, Koshiro Yoshii, Kentaro Kariwa, Hiroaki Sci Rep Article West Nile virus (WNV), a member of the Japanese encephalitis virus (JEV) serocomplex group, causes lethal encephalitis in humans and horses. Because serodiagnosis of WNV and JEV is hampered by cross-reactivity, the development of a simple, secure, and WNV-specific serodiagnostic system is required. The coexpression of prM protein and E protein leads to the secretion of subviral particles (SPs). Deletion of the C-terminal region of E protein is reported to affect the production of SPs by some flaviviruses. However, the influence of such a deletion on the properties and antigenicity of WNV E protein is unclear. We analyzed the properties of full-length E protein and E proteins lacking the C-terminal region as novel serodiagnostics for WNV infection. Deletion of the C-terminal region of E protein suppressed the formation of SPs but did not affect the production of E protein. The sensitivity of an enzyme-linked immunosorbent assay (ELISA) using the full-length E protein was higher than that using the truncated E proteins. Furthermore, in the ELISA using full-length E protein, there was little cross-reactivity with anti-JEV antibodies, and the sensitivity was similar to that of the neutralization test. Nature Publishing Group UK 2021-04-28 /pmc/articles/PMC8080695/ /pubmed/33911132 http://dx.doi.org/10.1038/s41598-021-88777-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Maezono, Keisuke
Kobayashi, Shintaro
Tabata, Koshiro
Yoshii, Kentaro
Kariwa, Hiroaki
Development of a highly specific serodiagnostic ELISA for West Nile virus infection using subviral particles
title Development of a highly specific serodiagnostic ELISA for West Nile virus infection using subviral particles
title_full Development of a highly specific serodiagnostic ELISA for West Nile virus infection using subviral particles
title_fullStr Development of a highly specific serodiagnostic ELISA for West Nile virus infection using subviral particles
title_full_unstemmed Development of a highly specific serodiagnostic ELISA for West Nile virus infection using subviral particles
title_short Development of a highly specific serodiagnostic ELISA for West Nile virus infection using subviral particles
title_sort development of a highly specific serodiagnostic elisa for west nile virus infection using subviral particles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080695/
https://www.ncbi.nlm.nih.gov/pubmed/33911132
http://dx.doi.org/10.1038/s41598-021-88777-5
work_keys_str_mv AT maezonokeisuke developmentofahighlyspecificserodiagnosticelisaforwestnilevirusinfectionusingsubviralparticles
AT kobayashishintaro developmentofahighlyspecificserodiagnosticelisaforwestnilevirusinfectionusingsubviralparticles
AT tabatakoshiro developmentofahighlyspecificserodiagnosticelisaforwestnilevirusinfectionusingsubviralparticles
AT yoshiikentaro developmentofahighlyspecificserodiagnosticelisaforwestnilevirusinfectionusingsubviralparticles
AT kariwahiroaki developmentofahighlyspecificserodiagnosticelisaforwestnilevirusinfectionusingsubviralparticles